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There were 109 articles published in the Journal of Cardiovascular Magnetic Resonance (JCMR) in 2013, which is a
21% increase on the 90 articles published in 2012. The quality of the submissions continues to increase. The editors
are delighted to report that the 2012 JCMR Impact Factor (which is published in June 2013) has risen to 5.11, up
from 4.44 for 2011 (as published in June 2012), a 15% increase and taking us through the 5 threshold for the first
time. The 2012 impact factor means that the JCMR papers that were published in 2010 and 2011 were cited on
average 5.11 times in 2012. The impact factor undergoes natural variation according to citation rates of papers in
the 2 years following publication, and is significantly influenced by highly cited papers such as official reports.
However, the progress of the journal's impact over the last 5 years has been impressive. Our acceptance rate is
<25% and has been falling because the number of articles being submitted has been increasing. In accordance
with Open-Access publishing, the JCMR articles go on-line as they are accepted with no collating of the articles
into sections or special thematic issues. For this reason, the Editors have felt that it is useful once per calendar
year to summarize the papers for the readership into broad areas of interest or theme, so that areas of interest
can be reviewed in a single article in relation to each other and other recent JCMR articles. The papers are
presented in broad themes and set in context with related literature and previously published JCMR papers to
guide continuity of thought in the journal. We hope that you find the open-access system increases wider
reading and citation of your papers, and that you will continue to send your quality manuscripts to JCMR for
publication.Vessel Wall & MR Angiography
Beside its key role in research, CMR is most frequently
used clinically for the carotid arteries where it can be
used to characterize thrombus, [1] plaque vulnerability,
[2] atheroma burden, natural history of progression, and
response to treatment. [3] However, peripheral artery
angiography, [4] and the role in investigation of pulmonary
hypertension, [5-8] vasculitis and systemic hypertension,
[9,10] is also making progress. This is an area of CMR
where 3T has had significant impact [11].* Correspondence: dj.pennell@rbht.nhs.uk
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unless otherwise stated.Vessel-wall imaging and quantification of flow-mediated
dilation using water-selective 3D SSFP-echo
A new flow suppression method for vessel wall imaging
using a steady state free precession (SSFP) sequence at
3T was described [12]. Flow sensitive water selective
excitation SSFP echo that results in spoiling of signal in
water protons of flowing blood due to phase incoherence
was used. Flow mediated dilation (FMD) was also ob-
tained from a peripheral artery. The proposed approach
discriminates effectively between vessel wall and lumen.
FMD results were qualitatively similar to values from
literature. Although measurement of FMD is acquired
from a very small group of individuals, it is still of reader
interest and this technique may be more useful at higher
field strengths.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gadobutrol: evaluation of the additional diagnostic
benefit in patients who have undergone a peripheral
magnetic resonance angiography protocol
This paper details the additional diagnostic benefits that
can be achieved with imaging during the blood-pool
phase following injection of an extracellular contrast
agent for peripheral contrast-enhanced angiography [13].
Although the study is retrospective, the analysis, discus-
sion and references list are comprehensive.Wall shear stress measured by phase contrast
cardiovascular magnetic resonance in children and
adolescents with pulmonary arterial hypertension
Phase-contrast imaging of the right pulmonary artery
was used to quantify local, temporal and circumfer-
entially averaged wall shear stress (WSS) and cross-
sectional area of the right pulmonary artery over
the cardiac cycle in children with PAH and young
healthy adults [14]. In the presence of preserved
flow rates through a large PAH pulmonary artery,
WSS was shown to be significantly decreased. This
may have implications for proximal pulmonary artery
remodeling and cellular function in the progression of
PAH.In-vivo quantitative T2 mapping of carotid arteries in
atherosclerotic patients: segmentation and T2
measurement of plaque components
This manuscript describes the quantitative T2 mapping
of carotid atherosclerotic plaques together with a semi-
automated classification method that segments the T2
maps into four classes: calcification, lipid rich necrotic
core, fibrous tissue and recent intraplaque haemorrhage
[15]. The overall agreement between semi-automated
classification of T2 maps compared to a gold-standard
manual segmentation in terms of overall AHA plaque-
type classification was good. The main limitations of the
study are is the lack of histological confirmation, which
the authors acknowledge.A case of a lesion containing an intracoronary thrombus
detected as hyperintense plaque on T1-weighted
cardiovascular magnetic resonance in a patient with
silent myocardial ischemia
This case report concerns non-invasive visualisation of
an intracoronary thrombus using T1 weighted inversion
recovery MRI in a patient with stable angina [16]. This
was subsequently confirmed by optical coherence tomog-
raphy and X-ray angiography. Findings from Thallium-
201 SPECT, coronary CTA and coronary MRA were also
discussed.Comparison of symptomatic and asymptomatic
atherosclerotic carotid plaques using parallel imaging
and 3 T black-blood in vivo CMR
The authors implemented a rapid multi-contrast carotid
plaque imaging protocol combining the increased SNR of
a 3T MR scanner with rapid acquisition using parallel
imaging [17]. The results demonstrate the advantage of
the multi-contrast MR approach to characterize various
carotid plaque components over just one MR sequence
to detect carotid plaque haemorrhage. The reduced
scanning time would be particularly useful for imaging
sick patients with acute stroke. The authors demonstrated
that symptomatic lesions can be identified but some of
the parameters showed overlap between the symptomatic
and asymptomatic lesions.
SHILO, a novel dual imaging approach for simultaneous
HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for
vascular dynamic contrast enhanced cardiovascular
magnetic resonance: numerical simulations and
feasibility in the carotid arteries
This manuscript describes a pulse sequence modification
that allows low resolution images to determine arterial
input function for pharmacokinetic modelling of con-
trast agent uptake in the carotid wall [18]. Only 5 pa-
tients were studied and there is no histological
comparison of results. Further investigation of this tech-
nique in wider studies measuring kinetic parameters of
plaque neovascularization and validation against gold
standard techniques are required.
Quantitative CMR markers of impaired vascular reactivity
associated with age and peripheral artery disease
The authors present a comprehensive CMR study of vas-
cular reactivity and vascular stiffness in patients with per-
ipheral arterial disease (PAD) and healthy volunteers (young
and old) [19]. Pre- and post-occlusive arterial hyperemia
was determined in the femoral artery and vein by time-
resolved blood flow velocity assessment and by the assess-
ment of the haemoglobin oxygenation level. Vascular stiff-
ness was determined by the pulse wave velocity, assessed in
the aortic arch. Compared to volunteers, patients with PAD
had a longer washout time of haemoglobin oxygen satur-
ation, and a delayed and decreased response. Antegrade fem-
oral arterial flow was prolonged, pulsatility was decreased
and pulse wave velocity was increased. The proposed
method represents an initial step towards development of
a potential tool for evaluation of intervention.
Reproducibility of rest and exercise stress contrast-enhanced
calf perfusion magnetic resonance imaging in peripheral
arterial disease
The inter-study and interobserver reproducibility as well
as potential utility of calf stress perfusion was shown in
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16 normal subjects (NL) [20]. Rest, exercise, and perfusion
reserve were measured by contrast-enhanced perfusion
MRI of the calf in NL and patients with PVD. The
authours concluded that although rest measures are
reproducible, they are quite low, do not distinguish NL
from PVD, and lead to variability in perfusion reserve
measures. Exercise tissue function and perfusion index
were the most reproducible measures in patients with
PVD for use in clinical trials.
Functionalization of gadolinium metallofullerenes for
detecting atherosclerotic plaque lesions by cardiovascular
magnetic resonance
This manuscript describes the development of a contrast
agent targeting the CD-36 receptor in atherosclerotic
plaque [21]. The authors provide description of the
manufacture and evaluation of the agent in Gd-containing
endohedrals. They show the time-dependent variation of
uptake of the agent in ApoE knockout mice and compare
that to wild type mice. A series of detailed and methodical
experiments was provided to prepare and characterize
the compounds used and to analyze their properties and
distribution.
Rapid prototyping compliant arterial phantoms for
in-vitro studies and device testing
This work describes a method of 3D printing to create
compliant vascular phantoms for use in CMR experimen-
tal studies [22]. The descriptions included two models, the
first being a patient-specific compliant hypoplastic aorta
suitable for connection in a mock circulatory loop for
in vitro tests and the second, a right ventricular outflow
tract (RVOT) of a patient in need of pulmonary valve re-
placement. This second model was printed in order to
physically test device insertion and assess patient’s suit-
ability for percutaneous pulmonary valve intervention.
Measured values of distensibility, compared with literature
data, show that the approach is suitable for manufacturing
arterial phantoms with representative anatomical finish-
ing, and quick and inexpensive fabrication.
Evolution of cardiac and renal impairment detected by
high-field cardiovascular magnetic resonance in mice with
renal artery stenosis
Renal artery stenosis (RAS) is an important underlying
cause of hypertension and cardiac dysfunction; the au-
thors used CMR to follow progressive cardiac and
renal dysfunction in mice with RAS [23]. Operated and
control mice were followed for 4 weeks. In the diseased
kidney, renal blood flow declined and BOLD showed
development of renal hypoxia. RAS animals also showed
evidence of LV hypertrophy with signs of early systolic
and diastolic dysfunction. CMR can be used to followprogressive cardiac and renal changes in the murine RAS
model.
Fast retrospectively triggered local pulse-wave velocity
measurements in mice with CMR-microscopy using a
radial trajectory
Aortic pulse-wave velocity (PWV) is an important de-
terminant of cardiovascular risk. Previous techniques
for measurement of PWV in mice required cardiac and
respiratory gating. The authors developed a robust self-
gated method to measure PWV without the need for trig-
gering [24]. This method will be useful for the study of
transgenic mice with altered vascular function.
Diffusion tensor imaging
Diffusion tensor imaging (DTI) gives information on the
mean intravoxel alignments of tissue microstructures
using diffusion weighted imaging. It is used in particular
in the brain, where larger diffusion values occur along
nerve fibres in comparison to across fibres. The technique
can also be used with considerably increased difficulty
(due to motion) for the heart, [25] however most work
has been done in animals, [26] or in ex-vivo human
hearts, because of the high difficulty of deriving DTI data
from the moving heart. Recently a more robust imaging
sequence for in-vivo human cardiac DTI has been de-
scribed which makes human studies more approachable
[27]. Recent work has shown in-vivo reproducibility in
humans in hypertrophic cardiomyopathy, [28] and histo-
logical validation in animals [29].
Correction: Reproducibility of in vivo diffusion tensor
cardiovascular magnetic resonance in hypertrophic
cardiomyopathy
The authors had previously reported the reproducibility
of using a stimulated-echo single-shot-EPI sequence
with zonal excitation and parallel imaging in 10 patients
with HCM scanned on 2 different days.28 This manuscript
represents a correction to an error in that paper [30].
The previous statement that results showed good repro-
ducibility of fractional anisotropy, mean diffusivity and
helical angle, indicating that current technology yields
robust in vivo measurements that have potential clinical
value is not changed by this correction. The interpretation
of regional differences in the septum requires further
investigation.
Congenital heart disease
CMR of congenital heart disease is relatively mature,
although quality acquisition and interpretation require
training. CMR is routinely used to investigate congenital
heart disease in children and adults, as a complement to
echocardiography, to avoid imaging with ionising radi-
ation, reduce the need for invasive diagnostic cardiac
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and approaches for both 3D balanced SSFP and magnetic
resonance angiography are improving [31]. Aortopathy
associated with congenital or inherited heart diseases is
common and the potential for CMR to triage patients is of
interest. There has been considerable recent interest in the
use of 4D flow imaging, which allows the visualisation of
large scale vorticity and the retrospective measurement of
flow in vessels within the volume covered [32,33].
Guidelines and protocols for cardiovascular magnetic
resonance in children and adults with congenital heart
disease: SCMR expert consensus group on congenital
heart disease.
CMR for congenital heart disease has an increasingly
valued role for routine diagnostic assessment, serial
clinical surveillance and pre procedural planning. The
authors of this paper are experienced and expert in the
field and give helpful guidelines and consensus recom-
mendations for the performance of CMR in children
and adults with congenital heart disease [34]. Common
core techniques are discussed and disease specific protocols
recommended.
Demonstration of value of optimizing ECG triggering for
cardiovascular magnetic resonance in patients with
congenital heart disease
The authors investigated blood flow quantification in 35
patients with varied congenital heart disease using both a
new ECG trigger algorithm and an old EGG trigger algo-
rithm [35]. Increased specificity, sensitivity and accuracy
of QRS detection was found with the new ECG triggering
algorithm. Differences of more than 5% blood flow quanti-
fication were seen in approximately 1/3 of cases support-
ing that optimization of ECG triggering during routine
CMR is needed in routine congenital heart disease CMR.
Preliminary experience with cardiovascular magnetic
resonance in evaluation of fetal cardiovascular anomalies
A relatively large contemporary clinical experience is re-
ported of fetal CMR in 68 pregnant women studied at
mean gestational age 25.5 weeks for further clarification
of congenital heart disease [36]. CMR yielded the same
diagnosis as postnatal findings in 79%. Fetal cardiac con-
tractility and valvular function cannot be assessed and
small defects were sometimes missed; nevertheless this
preliminary experience suggests that fetal CMR may be
a promising future assessment tool.
Fetal circulation in left-sided congenital heart disease
measured by cardiovascular magnetic resonance: a
case–control study
Interest is growing in the ability of CMR to elucidate
pathophysiological mechanisms and in future to evaluateabnormalities of anatomy of function not readily depicted
with fetal echocardiography. The relationships between
fetal haemodynamics and lung and brain development
were examined by Al Nafisi and colleagues. Phase contrast
CMR in 22 fetuses with suspected left sided lesions at a
single late gestation timepoint (around 35 weeks) was
used to determine fetal blood flow distribution and values
compared with their previously reported 12 normal con-
trols [37]. Fetuses with left-sided CHD had a mean com-
bined ventricular output 19% lower than normal controls.
Fetal brain weight below the 5th centile was seen only in
CHD fetuses (n=6) [38]. The authors suggest that the
mechanisms of fetal developmental delay in congenital
heart disease are a priority for study and that future stud-
ies combining fetal brain MRI and phase contrast CMR
could contribute.
PINOT NOIR: Pulmonic INsufficiency imprOvemenT with
Nitric Oxide Inhalational Response
Sixteen patients with at least moderate pulmonary regur-
gitation on echocardiogram with either repaired tetralogy
of Fallot (n=11) or previous surgery for pulmonary sten-
osis (n=5) were prospectively studied with CMR before
and during 40ppm inhaled nitric oxide [39]. At baseline,
mean pulmonary regurgitant fraction was 35+/−16% and
mean RVEDVi and RVESVi were 157+/−33 and 93+/−20
mL/m2, respectively. Nitric oxide reduced pulmonary
regurgitant fraction by an average of 5+/−8%. However,
there was no reduction in right ventricular volume indices
which are currently used to help determine timing of pul-
monary valve replacement. The longer term effects of se-
lective pulmonary vasodilator therapy might be of interest.
Inflow-weighted pulmonary perfusion: comparison
between dynamic contrast-enhanced MRI versus perfusion
scintigraphy in complex pulmonary circulation
Pulmonary scintigraphy is the current convention when
assessing regional pulmonary perfusion. In contrast to
Technetium labelled macroaggregated albumin, gadolin-
ium chelate is only nanometers in size so can pass freely
into capillaries to the systemic circulation and recircu-
late in normal lungs or abnormally via shunt/collateral
flow in pathological lungs. Where present these abnormal-
ities can cause discrepancy between conventional indicator
dilution and inflow-weighted analysis methods because the
discrepancy represents a mixed-flow component in which
pathological flow such as shunting or collaterals might have
participated. Based on 26 retrospectively analysed data sets
in 22 patients that underwent pulmonary scintigraphy and
dynamic contrast enhanced MR as part of another research
study, the authors demonstrate a method for CMR-derived
inflow weighted regional pulmonary perfusion maps
that results in a close match to the gold standard pulmon-
ary scintigraphy [40]. It appears that dynamic contrast
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theory combined with the newly proposed inflow-weighted
analysis could be an attractive substitute for pulmonary
scintigraphy in pediatric patients where avoidance of ionis-
ing radiation is highly desirable.
Flow
The measurement of flow using CMR has become le-
gion in the cardiovascular system reflecting its central
importance. While some technical issues still need to be
addressed to overcome to achieve consistency between
manufacturers and centres, [41] recent applications have
included left atrial appendage emptying, [42] aortic wave
intensity analysis, [43] and robust cardiac output measure-
ment [44].
Assessment of ductal blood flow in newborns with
obstructive left heart lesions by cardiovascular magnetic
resonance
Direct CMR measurement of direction and volume of
ductal flow was feasible and analysed in 32 newborn
patients with left sided obstructive heart disease [45].
Patients with smaller left ventricles and lower ascending
aortic flow had a greater contribution of ductal flow to the
systemic circulation. The size of the ductus arteriosus did
not predict net ductal flow. Comparison with contempor-
aneous echocardiography was not made in this retrospect-
ive study.
Aorta
CMR is widely used for assessment of the aorta in both
congenital and acquired conditions and is particularly
well suited longitudinal follow-up of aortic dimensions,
and more complex aspects of aortic function, such as
pulse wave velocity, distensibility and shear stress [46-48].
Cardiovascular Magnetic Resonance in Marfan syndrome
This is a comprehensive overview of the cardiovascular
manifestations of Marfan syndrome and the role of CMR
in their evaluation [49]. The paper is nicely illustrated
and addresses an important but often under-appreciated
disorder.
Aortic arch shape is not associated with hypertensive
response to exercise in patients with repaired congenital
heart diseases
Exercise induced hypertension is a complication of
successful coarctation repair and has been previously
suggested to be due to a gothic arch morphology post
repair. Ntsinjana and colleagues studied 60 subjects
(20 controls, 20 post repair of coarctation and 20 post
arterial switch operation for transposition of the great
arteries) with bicycle cardiopulmonary exercise testing
for blood pressure response to exercise and same dayCMR MRA for quantitative geometrical analysis [50].
Arch curvature was similar in post coarctation and arterial
switch patients but different from controls. Transverse
arch and isthmus hypoplasia, not acute arch angulation
(“gothic arch”) were associated with pathophysiological
blood pressure response to exercise. These data suggest
attention should be paid to the size of the residual arch at
interventions as this is at least one factor contributing to
the abnormal blood pressure response.
Prediction of aortic dilation in Turner syndrome - enhancing
the use of serial cardiovascular magnetic resonance
Women with Turners may develop aortic dilatation of
the ascending or descending aorta and are at 100 fold
increased risk of aortic dissection. Known risk factors
fail to predict dissection in an important proportion.
Towards future optimization of triage of these patients,
in this study adult women with Turners (n=102) were
prospectively followed with CMR over 5 years with aortic
assessment at 9 positions and 3 time points (baseline,
mean 2.4 years and at mean 4.8 years) [51]. Mathematical
models integrating all measurements at all timepoints as
well as known risk factors for aortic disease were made to
forecast aortic diameter. Aortic coarctation (P < 0.0001), bi-
cuspid aortic valve (P < 0.0001), advanced age (P < 0.0001),
diastolic blood pressure (P = 0.0008), body surface area
(P = 0.015) and antihypertensive treatment (P = 0.005)
all preferentially accelerated aortic diameter. With the
model it was possible to identify Turners patients at low
and high risk for rapidly progressive aortic growth.
T1 mapping & extracellular volume
Myocardial assessment by T1 mapping is the technique
of the moment, and there has been a large expansion in
papers published on this subject in JCMR and elsewhere as
its robustness and clinical role becomes defined [52-56].
Myocardial T1 mapping and extracellular volume
quantification: a Society for Cardiovascular Magnetic
Resonance (SCMR) and CMR Working Group of the
European Society of Cardiology consensus statement
This consensus statement addresses the rapid innovations
in CMR enabling the tracking of biologically important
changes in the myocardium by: a) native T1 that reflects
myocardial disease involving the myocyte and interstitium
without use of gadolinium based contrast agents (GBCA),
or b) the extracellular volume fraction (ECV)–a direct
GBCA-based measurement of the size of the extracellu-
lar space, reflecting interstitial disease [57]. The latter
technique attempts to dichotomize the myocardium into
its cellular and interstitial components with estimates
expressed as volume fractions. This document provides
recommendations for clinical and research T1 and ECV
measurement, based on published evidence when available
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preparation, scan type, scan planning and acquisition,
quality control, visualisation and analysis, technical de-
velopment. The authors highlight the need for more
research before a large-scale application for clinical
decision-making can be recommended.
Standardization of T1 measurements with MOLLI in
differentiation between health and disease – the
ConSept study
In this study, the authors highlight that T1 imaging
based on pixel-wise quantification of longitudinal relax-
ation has the potential to differentiate between normal
and abnormal myocardium but that the accuracy of T1
measurement has not been established nor systematic-
ally tested in the presence of health and disease [58].
Intra-observer, inter-observer and inter-study reprodu-
cibility of T1 imaging was assessed in subjects with left
ventricular hypertrophy (LVH, n = 25) or dilated cardio-
myopathy (DCM, n = 43). Thirty-eight subjects with
low-pretest likelihood of cardiomyopathy served as a
control group. T1 values were acquired in a single mid-
ventricular short axis slice using modified Look-Locker
imaging prior and after the application of gadolinium
contrast at 1.5 and 3 T. Analysis was performed with
regions of interest (ROI) placed conservatively within
the septum or to include the whole short axis (SAX)
myocardium. Conservative septal ROI T1 measurement
was found to be a robust technique with good intra-
observer, inter-observer and inter-study reproducibility for
native and post-contrast T1 value and partition coefficient
measurements. An important conclusion the authors
make is that native septal T1 values revealed the greatest
difference between normal and abnormal myocardium,
which is independent of geometrical alterations of cardiac
chamber and wall thickness. Accordingly, they propose
the use of native T1 measurements using conservative
septal technique as the standardized approach to distin-
guish health from disease assuming diffuse myocardial
involvement.
Normal variation of magnetic resonance T1 relaxation
times in the human population at 1.5 T using ShMOLLI
In this study, the authors aimed to establish the normal
range, potential sources of error and confounders of
native myocardial T1 relaxation times in a large cohort
of healthy human volunteers [59]. T1-mapping was per-
formed at 1.5T using the Shortened Modified Look-Locker
Inversion Recovery (ShMOLLI) technique. They reported
the effects of normal physiologic parameters, including age,
gender, heart rate, weight, height and hematocrit, as well as
technical factors, such as partial volume effects, myocardial
thickness and inter-centre variability on identical scanners
within and across three clinical centres in two countries. Alarge cohort of healthy volunteers (n = 342), from 3 clinical
centres across two countries underwent CMR at 1.5T.
Native myocardial ShMOLLI T1 was 962 ± 25 ms. They
identified the partial volume as primary source of po-
tential error in the analysis of respective T1 maps and
use 1 pixel erosion to represent “midwall myocardial”
T1, resulting in a 0.9% decrease to 953 ± 23 ms. Midwall
myocardial ShMOLLI T1 was reproducible with an intra-
individual, intra- and inter-scanner variability of ≤2%. The
principle biological parameter influencing myocardial
ShMOLLI T1 was the female gender. After correction for
age and gender dependencies, heart rate was the only
other physiologic factor with a small effect on myocardial
ShMOLLI T1. Left and right ventricular blood ShMOLLI
T1 correlated strongly with each other and also with
myocardial T1. Overall, the effect of all variables on
myocardial ShMOLLI T1 was within 2% of relative
changes from the average. They concluded that native
T1-mapping using ShMOLLI generates reproducible
and consistent results in normal individuals within 2%
of relative changes from the average. The main potential
confounder is the partial volume effect arising from over-
inclusion of neighbouring tissue at the manual stages of
image analysis. In the study of cardiac conditions such
as diffuse fibrosis or small focal changes, the use of
“myocardial midwall” T1, age and gender matching, and
compensation for heart rate differences may all help to
improve the method sensitivity in detecting subtle
changes. ShMOLLI is a stable and reproducible method
for T1-mapping.
Myocardial T1 and T2 mapping at 3 T: reference values,
influencing factors and implications
T1 and T2 mapping of the left ventricular myocardium,
i.e. quantification of the myocardial T1 and T2 relaxation
times, as well as the T1-derived extracellular volume frac-
tion have been demonstrated to add valuable information.
Most of the experience with myocardial mapping was
gained at a magnetic field strength of 1.5 T. Parametric
myocardial mapping at 3 T is conceptually appealing due
to the signal gain inherent to higher fields, which may be
exploited for improved spatial and temporal resolution.
Many of the previous studies focused on intra-individual
comparison of diseased and remote myocardium. However,
T2 and T1 reference values of all myocardial segments may
be important to define small focal abnormalities and to
identify diffuse tissue changes in the absence of healthy
“remote” myocardium. This study aimed at analyzing the
feasibility of T1 and T2 mapping at 3 T and providing
reference values [60]. Sixty healthy volunteers (30 males/
30females, with 20 each from 20–39 years, 40–59 years,
60–80 years) underwent left-ventricular T1 and T2 map-
ping in 3 short-axis slices at 3 T. For T2 mapping, 3
single-shot steady-state free precession (SSFP) images
Pennell et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:100 Page 7 of 29
http://jcmr-online.com/content/16/1/100with different T2 preparation times were acquired. For T1
mapping, modified Look-Locker inversion recovery tech-
nique with 11 single shot SSFP images was used before
and after injection of gadolinium contrast. T1 and T2
relaxation times were quantified for each slice and each
myocardial segment. Myocardial T2 and T1 reference
values for the specific CMR setting are provided. The
authors observe that the diagnostic impact of the high
inter-subject variability of T2 and T1 relaxation times
requires further investigation.
Diffuse myocardial fibrosis by T1-mapping in children
with subclinical anthracycline cardiotoxicity: relationship
to exercise capacity, cumulative dose and remodeling
Despite the effectiveness of anthracycline chemotherapy,
cardiotoxicity remains a significant long-term secondary
effect. The myofibrillar loss and cellular necrosis from
anthracycline cardiotoxicity leads to delayed and irrevers-
ible myocardial damage, culminating in cardiac dysfunc-
tion, cardiomyopathy and heart failure. The aim of this
study was to determine the CMR tissue characteristics
(myocardial T1, T2 and derived ECV) in subclinical myo-
cardial toxicity and their association with LV function and
structure, exercise capacity and chemotherapy dose in
childhood and adolescent cancer survivors [61]. Thirty pa-
tients (15 ± 3 years), at least 2 years following anthracy-
cline treatment, underwent CMR, echocardiography, and
cardiopulmonary exercise testing (peak VO2). CMR mea-
sured ventricular function, mass, T1 and T2 values, and
myocardial extracellular volume fraction, ECV, a measure
of diffuse fibrosis based on changes in myocardial T1
values pre- and post-gadolinium. Cardiac function was also
assessed with conventional and speckle tracking echocardi-
ography. Patients had normal LVEF (59 ± 7%) but peak
VO2 was 17% lower than age-predicted normal values and
were correlated with anthracycline dose (r = −0.49). In-
creased ECV correlated with decreased mass/volume
ratio (r = −0.64), decreased LV wall thickness/height
ratio (r = −0.72), lower peak VO2(r = −0.52), and higher
cumulative dose (r = 0.40). Echocardiographic measures of
systolic and diastolic function were reduced compared to
normal values (p < 0.01), but had no relation to ECV, peak
VO2 or cumulative dose. Myocardial T1 and ECV were
found to be early tissue markers of ventricular remodeling
that may represent diffuse fibrosis in children with normal
ejection fraction post anthracycline therapy, and are re-
lated to cumulative dose, exercise capacity and myocardial
wall thinning.
Modified look-locker inversion recovery T1 mapping
indices: assessment of accuracy and reproducibility
between magnetic resonance scanners
This study presents results on the accuracy and reprodu-
cibility of MOLLI T1 measurements on two differentMR manufactured systems each at two different field
strengths 1.5 Tesla and 3 Tesla [62]. The T1 of Gel
phantoms is systematically measured and repeated on
multiple MR systems for heart rates from 40 to 100
beats per min. Results are compared to those from the
gold standard IR-SE T1 sequence. Errors in T1 are also
compared to errors in partition coefficient as calculated
from combined measurements in phantoms with a high
and a low T1 and the results show that the range of T1
errors is higher than that of errors for the partition
coefficient.
Influence of off-resonance in myocardial T1-mapping
using SSFP based MOLLI method
This manuscript studies the errors in T1 mapping due
to properties of the SSFP readout in the approach to
steady-state, where the signal intensity depends on both
the off-resonance frequency and magnetization prepar-
ation [63]. The results show that the most commonly
used MOLLI variant with a flip angle of 35 degrees can
yield relatively large errors in non-contrast myocardial
T1 values. These are important in magnitude given the
low variability in the T1 values routinely achieved, which
offer the ability to detect pathology with differences in T1.
The study also shows that the effects are more pronounced
at 3T. Studies such as this will be important in the push to
clinically translate these methods.
T1 and extracellular volume mapping in the heart:
estimation of error maps and the influence of noise on
precision
The manuscript describes a detailed and accurate method
for calculating the error in the T1 measurement on a pixel
by pixel basis [64]. The approach used is a standard error
analysis method, but it has been applied to these cardiac
T1 and ECV mapping data. The method produces Stand-
ard Deviation (SD) maps for each T1 and ECV map and
the pixel SD estimates are validated by numerical simula-
tion using Monte-Carlo analysis and with phantoms using
repeated trials. SD estimates are provided for pre-and
post-contrast optimized protocols for a range of T1s and
SNRs. The authors conclude that the ability to quantify
the measurement error has potential to determine the
statistical significance of subtle abnormalities that arise
due to diffuse disease processes involving fibrosis and/or
edema and is useful both as a confidence metric for over-
all quality, and in optimization and comparison of imaging
protocols.
Correction with blood T1 is essential when measuring
post-contrast myocardial T1 value in patients with acute
myocardial infarction
Post-contrast T1 mapping using modified Look-Locker
inversion recovery sequence has been introduced as a
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extra-cellular space even in the absence of scarring. As
the degree of left ventricular (LV) myocardial fibrosis
can differ from segment to segment, especially in pa-
tients with ischemic heart disease, multiple slicing is
needed to see regional differences in T1 values. How-
ever, post-contrast T1 value can change over time after
bolus contrast injection. In this study, the authors investi-
gated the changes of the T1 values according to multiple
slicing over scanning time at 15 minutes after contrast
injection and usefulness of blood T1 correction [65]. They
also evaluated correction methods to provide better time-
independent results during multiple short-axis slicing.
Eighteen reperfused acute myocardial infarction (AMI)
patients, 13 cardiomyopathy patients and 8 healthy volun-
teers underwent cardiovascular magnetic resonance with
15 minute-post contrast MOLLI to generate T1 maps. In
10 cardiomyopathy cases, pre- and post-contrast MOLLI
techniques were performed to generate extracellular
volume fraction (Ve). Six slices of T1 maps according to
the LV short axis, from apex to base, were consecutively
obtained. Each T1 value was measured in the whole
myocardium, infarcted myocardium, non-infarcted myo-
cardium and LV blood cavity. They found that post-
contrast 15-minute myocardial T1 value increased over
time but the ratio of myocardial T1/blood T1 was rather
stable. The Ve calculated using pre-, post- MOLLI se-
quence and blood hematocrit level, was stable throughout
the entire myocardial region. They recommend using
15-minute-post-contrast myocardial T1 values after
correcting for blood T1 or calculated Ve when multiple
slicing is conducted over time.
Interventional CMR
Few subjects create as much interest clinically as the
potential for replacement of x-ray based interventional
procedures by those under MR guidance. The design of
interventional devices has continued to advance, [66-68]
and the field was recently reviewed [69].
Real-time cardiovascular magnetic resonance subxiphoid
pericardial access and pericardiocentesis using
off-the-shelf devices in swine
This study assesses whether interventional CMR could
allow enhanced safer image guidance for needle access
for drainage of pericardial effusion [70]. Traditional
guidance procedures using 2D projection angiography
or ultrasound, carry the risk that the needle location
and trajectory can be misjudged potentially resulting in
serious complications or even death. This study uses
real-time CMR to guide subxiphoid pericardial access
in naïve swine using commercial 18G titanium puncture
needles, which are exchanged for pericardial catheters.
To test the value of CMR needle pericardiocentesis, theauthors also created intentional pericardial effusions of a
range of volumes, via a separate transvenous-transatrial
catheter. The authors concluded that the experience from
this study supports clinical testing of real-time CMR
guided needle access or drainage of the pericardial space.
Transthoracic delivery of large devices into the left
ventricle through the right ventricle and interventricular
septum: preclinical feasibility
In 9 of 11 pigs, real time CMR guidance successfully
allowed LV cannulation via the chest, RV free wall and
the interventricular septum, and subsequent closure of
the RV free wall with an occluder device; one failure was
due to refractory ventricular fibrillation and one from
inadequate guidewire support [71]. The septum recoiled
immediately and complete healing was demonstrated
with oximetry, angiography, CMR and necropsy up to 4
weeks later. The entry angle for accessing the left sided
chambers is more favourable than the conventional atrial
transseptal approach which may be attractive when con-
sidering transcatheter mitral valve interventions.
Pediatric cardiovascular interventional devices: effect on
CMR images at 1.5 and 3 Tesla
Using ex-vivo phantom experiments, 11 different pediatric
transcatheter devices (stainless steel or nitinol) were eval-
uated at 1.5 and 3.0 Tesla for the influence of magnetic
field strength, pulse sequence type, device orientation, flip
angle and voxel size on the type and extent of CMR
artifact [72]. Stainless steel embolization coils rendered
large surrounding zones uninterpretable whilst remaining
devices cause mild artifact. The strength of the magnetic
field, device composition, sequence type and orientation
of the device in B0 had the largest impact on the amplifi-
cation factor (ratio of signal void dimension to true device
dimension) of implanted devices in an MR environment
Cardiomyopathy
The phenotyping of cardiomyopathy is a primary clinical
indication for CMR, [73] and has become mainstream in
hypertrophic cardiomyopathy [74-77]. Recent attention
has been focussed on the assessment of diffuse fibrosis
in cardiomyopathy using T1 imaging, [78,79] and novel
investigations in less common conditions [80-83].
Left ventricular noncompaction in Duchenne muscular
dystrophy
In this study, the authors report on left ventricular
noncompaction (LVNC) in the Duchenne Muscular Dys-
trophy (DMD) population and characterize its relationship
to global LV function [84]. CMR was used to assess
ventricular morphology and function in 151 subjects:
DMD with ejection fraction (EF) > 55% (n = 66), DMD
with EF < 55% (n = 30), primary LVNC (n = 15) and
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pacted (NC/C) ratio was measured in each of the 16
standard myocardial segments. LVNC was defined as a
diastolic NC/C ratio > 2.3 for any segment. LVNC criteria
were met by 27/96 DMD patients (prevalence of 28%):
11 had an EF > 55% (prevalence of 16.7%), and 16 had
an EF < 55% (prevalence of 53.3%). The median max-
imum NC/C ratio was 1.8 for DMD with EF > 55%, 2.46
for DMD with EF < 55%, 1.54 for the normal subjects,
and 3.69 for primary LVNC patients. Longitudinal data
for 78 of the DMD boys demonstrated a mean rate of
change in NC/C ratio per year of +0.36. The high preva-
lence of LVNC in DMD was associated with decreased
LV systolic function that develops over time and may
represent muscular degeneration versus compensatory
remodeling.
Prevalence and distribution of late gadolinium enhancement
in a large population of patients with Duchenne muscular
dystrophy: effect of age and left ventricular systolic function
Duchenne muscular dystrophy (DMD), an X-linked re-
cessive disorder affecting approximately 1 in 5000 males,
is the most common inherited muscular dystrophy. The
disease results from mutations in the gene for dys-
trophin, a sarcolemmal protein that is abundant in both
cardiac and skeletal muscle. Progressive skeletal muscle
weakness results in loss of ambulation between 7 and 13
years of age. DMD-associated cardiac disease is progres-
sive and ultimately results in global ventricular systolic
dysfunction, often with minimal ventricular dilation.
End-stage cardiac pathology includes cardiomyocyte
hypertrophy, atrophy and fibrosis. In this study, the au-
thors sought to establish a) prevalence and distribution
of LGE in a large DMD population and b) relationship
among LGE, age, LVEF by CMR and current living status
[85]. They demonstrate that LGE occurs early, is progres-
sive and increases with both age and decreasing LVEF.
Segmentally, the incidence of the number of positive LGE
segments increase with age and lower LVEF. Older pa-
tients and those who died during the study period had
more septal LGE involvement. The current studies suggest
that the time course and distribution of LGE-positivity
may be an important clinical biomarker to aid in the man-
agement of DMD-associated cardiac disease.
Arrhythmogenic right ventricular cardiomyopathy mimics:
role of cardiovascular magnetic resonance
CMR is commonly used in patients with suspected
arrhythmogenic right ventricular cardiomyopathy (ARVC).
However, various diseases may present with clinical features
resembling ARVC causing diagnostic dilemmas. This study
explored the role of CMR in the differential diagnosis
of 657 patients with suspected ARVC. Twenty patients
(3.0%) fulfilled imaging ARVC criteria [86]. Thirty (4.6%)had a potential ARVC mimic, of which 25 (3.8%) were
considered clinically important. In conclusion, some pa-
tients referred for CMR with suspected ARVC fulfil ARVC
imaging criteria but more have otherwise unrecognised
diseases mimicking potentially ARVC. Clinical assessment
should emphasize the assessment of potential mimics in
parallel with the detection of ARVC.
Pulmonary blood volume indexed to lung volume is
reduced in newly diagnosed systemic sclerosis compared
to normals – a prospective clinical cardiovascular magnetic
resonance study addressing pulmonary vascular changes
Pulmonary involvement, either by pulmonary arterial
hypertension or pulmonary fibrosis, is the most common
cause of death in systemic sclerosis (SSc). The authors
explored the feasibility of detecting early pulmonary in-
volvement in SSc using non-invasive quantitative mea-
sures of pulmonary physiology by CMR. Compared to
healthy controls, the pulmonary blood volume (PBV)
indexed to lung volume (PBVI) was lower in newly diag-
nosed SSc patients. There was no significant correlation
between PBVI and pulmonary artery pressure estimated
by Doppler, lung’s diffusion capacity for carbon monox-
ide, vital capacity, or pulmonary fibrosis by CT. Hence
PBVI may be a novel parameter reflecting vascular lung
involvement in early-stage SSc [87].
Varied distributions of late gadolinium enhancement found
among patients meeting cardiovascular magnetic resonance
criteria for isolated left ventricular non-compaction
The aim of this retrospective study was to describe the
frequency and distribution of LGE in patients considered
to meet CMR cine imaging criteria for LVNC [88].
Forty-seven patients meeting standard CMR criteria for
LVNC were studied. Mean number of non-compacted
segments per patient was 7.4 ± 2.5 and the NC:C was
3.2 ± 0.7. Non-compaction was most commonly noted in
the apical segments in all patients. LGE was present in
40%, and most often located in the ventricular septum.
The distribution of LGE was subendocardial (n = 5; 6%),
mid-myocardial (n = 61; 68%), subepicardial (n = 10; 11%),
and transmural (n = 14; 15%) in total of 90 LGE (+) seg-
ments. LGE distribution was noted to be heterogeneous
with appearances potentially attributable to three or more
distinct cardiomyopathic processes. The authors observe
that further work is needed to determine whether condi-
tions such as dilated cardiomyopathy, previous myocardi-
tis or ischaemic heart disease increase the apparent depth
of non-compact relative to compact myocardium.
Quantification of left ventricular trabeculae using fractal
analysis
The identification by imaging of left ventricular non-
compaction (LVNC) is challenging and relatively subjective.
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measurement of the fractal dimension (FD) of the LV
endocardial border [89]. This dimension, indicative of
boundary complexity or fragmentation, was found to be
higher in 30 patients assessed by the Jenni echocardio-
graphic criteria as having LVNC compared to healthy
volunteers. It was also higher in healthy blacks (n=30)
than healthy whites (n=36). Fractal analysis, which is
likely to be dependent on image resolution, was consid-
ered to provide a quantitative measure of trabeculation
with high reproducibility and accuracy for LVNC diagno-
sis as compared to previous CMR criteria based on the
linearly measured proportions of trabeculated to compact
layers as seen in long axis cines.
Heterogeneous abnormalities of in-vivo left ventricular
calcium influx and function in mouse models of muscular
dystrophy cardiomyopathy
Manganese-enhanced CMR (MECMR) can non-invasively
assess myocardial calcium influx, and in this study, the
authors examined whether myocardial calcium levels are
elevated in vivo in two mouse models of muscular
dystrophy cardiomyopathy, the mdx mice (model of
Duchenne Muscular Dystrophy) and Sgcd−/− mice
(Limb Girdle Muscular Dystrophy) [90]. Both mouse
models exhibited increased in-vivo calcium influx at an
early stage in the development of the cardiomyopathy
before left ventricular hypertrophy occurred. This study
shows the capability of MECMR to measure calcium
fluxes in vivo.
On myocardial siderosis and left ventricular dysfunction
in hemochromatosis
Chronically increased intestinal iron uptake in genetic
hemochromatosis (HC) may cause organ failure. Whilst
iron loading from blood transfusions may cause dilated
cardiomyopathy in conditions such as thalassemia, the
in-vivo prevalence of myocardial siderosis in HC is un-
clear, and its relation to left ventricular (LV) dysfunction
is controversial. Most previous data on myocardial side-
rosis in HC has come from post-mortem studies. In this
paper, T2* CMR was performed at first presentation of
41 HC patients (58.9 ± 14.1 years) to measure myocar-
dial iron and left ventricular (LV) ejection fraction (EF).
In 31 patients (genetically confirmed HFE-HC), the HFE
genotype was C282Y/C282Y (n = 30) and C282Y/H63D
(n = 1) [91]. Patients with other genotypes (n = 10) were
labeled genetically unconfirmed HC. Of the genetically
confirmed HFE-HC patients, 6 (19%) had myocardial
siderosis (T2* <20 ms). Of these, 5 (83%) had heart failure
and reduced LVEF which was correlated to the severity of
siderosis (R2 0.57, p = 0.049). Two patients had follow-up
scans and both had marked improvements in T2* and
LVEF following venesection. Myocardial siderosis waspresent in 6/18 (33%) of patients with presenting ferritin ≥
1000 μg/L at diagnosis but in 0/13 (0%) patients with
ferritin <1000 μg/L (p = 0.028). Overall however, the
relation between myocardial siderosis and ferritin was
weak (R2 0.20, p = 0.011). In the 10 genetically uncon-
firmed HC patients, 1 patient had mild myocardial
siderosis but normal EF. Of all 31 patients, 4 had low
LVEF from other identifiable causes without myocar-
dial siderosis. The authors concluded: myocardial side-
rosis was present in 33% of newly presenting genetically
confirmed HFE-HC patients with ferritin >1000 μg/L, and
was the commonest cause of reduced LVEF; Heart failure
due to myocardial siderosis was only found in these HFE-
HC patients, and was reversible with venesection; and that
myocardial iron was normal in patients with other causes
of LV dysfunction.
Cardiac and hepatic iron and ejection fraction in
thalassemia major: multicentre prospective comparison of
combined deferiprone and deferoxamine therapy against
deferiprone or deferoxamine monotherapy
Due to the limited data available in literature, the aim
of this multi-centre study was to prospectively com-
pare in thalassemia major (TM) patients the efficacy of
combined deferiprone (DFP) and deferoxamine (DFO)
regimen versus either DFP and DFO in monotherapy
by CMR (CMR) over a follow up of 18 months. Among
the first 1135 TM patients in the MIOT (Myocardial
Iron Overload in Thalassemia) network, those who had
received either combined regimen (DFO + DFP, N=51)
or DFP (N=39) and DFO (N=74) monotherapies were
evaluated between the two CMR scans. Iron overload
was measured by T2* multiecho technique [92]. Biven-
tricular function parameters were quantitatively evalu-
ated by cine images. The percentage of patients that
maintained a normal global heart T2* value was com-
parable between DFP+DFO versus both monotherapy
groups. Among the patients with myocardial iron over-
load at baseline, the changes in the global heart T2*
and in biventricular function were not significantly dif-
ferent in DFP+DFO compared with the DFP group.
The improvement in the global heart T2* was signifi-
cantly higher in the DFP+DFO than the DFO group,
without a difference in biventricular function. Among
the patients with hepatic iron at baseline, the decrease
in liver iron concentration values was significantly
higher with combination therapy than with either mono-
therapy group. The authors concluded that in TM patients
at the dosages used in the real world, the combined
DFP+DFO regimen was more effective in removing
cardiac iron than DFO, and was superior in clearing
hepatic iron than either DFO or DFP monotherapy.
Combined therapy did not show an additional effect on
heart function over DFP.
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scarring in adult patients with sickle cell disease: a
comprehensive magnetic resonance assessment of
hepatic and myocardial iron overload
Patients with Sickle cell disease (SCD) who receive regu-
lar transfusions are at risk for developing cardiac toxicity
from iron overload. The aim of this study was to assess
right and left cardiac volumes and function, late gadolin-
ium enhancement (LGE) and iron deposits in patients
with SCD using CMR, correlating these values with
transfusion burden, ferritin and hemoglobin levels [93].
Thirty patients with SCD older than 20 years of age were
studied in a 1.5 T scanner and compared to age- and
sex-matched normal controls. Patients underwent ana-
lysis of biventricular volumes and function, LGE and
T2* assessment of the liver and heart. When compared
to controls, patients with SCD presented higher left ven-
tricular (LV) volumes with decreased ejection fraction
(EF) with an increase in stroke volume (SV) and LV
hypertrophy. The right ventricle (RV) also presented
with a decreased EF and hypertrophy, with an increased
end-systolic volume. Although twenty-six patients had
increased liver iron concentrations (median liver iron
concentration value was 11.83 ± 9.66 mg/g), only one
patient demonstrated an abnormal heart T2* < 20 msec.
Only four patients (13%) had LGE, with only one patient
with an ischemic pattern. The authors concluded that
abnormal heart iron levels and myocardial scars are not
a common finding in SCD despite increased liver iron
overload. The significantly different ventricular function
seen in SCD compared to normal suggests the changes
in RV and LV function may not be due to the anemia
alone. Future studies are necessary to confirm this
association.
Understanding cardiovascular injury after treatment for
cancer: an overview of current uses and future directions
of cardiovascular magnetic resonance.
Cancer-free survival has improved over the past 20 years
for many individuals with prostate, renal, breast, and
hematologic malignancies, but an increasingly recognized
prevalence of cardiovascular (CV) events in cancer survi-
vors has been an unintended consequence of many of the
therapies that have improved these survival rates. The in-
crease in CV events threatens to offset the improvement
in cancer related survival. As a result, there is an emerging
need to develop methods to identify those individuals
treated for cancer at increased risk of cardiovascular
events. With its inherent ability to characterize myocardial
tissue and identify both cardiac and vascular dysfunction,
CMR has the potential to identify both subclinical and
early clinical CV injury before the development of an
overt catastrophic event such as a myocardial infarction,
stroke, or premature cardiac death. Early identificationprovides an opportunity for the implementation of pri-
mary prevention strategies to prevent such events, thereby
improving overall cancer survivorship and quality of life.
This article reviews the etiology of CV events associated
with cancer therapy and the unique potential of CMR to
provide early diagnosis of subclinical CV injury related to
the administration of these therapies [94].
Treatment of heart failure in adults with thalassemia
major: response in patients randomised to deferoxamine
with or without deferiprone.
Established heart failure in thalassaemia major has a
poor prognosis and optimal management remains unclear.
This was a 1 year prospective study comparing deferox-
amine (DFO) monotherapy or when combined with defer-
iprone (DFP) for patients with left ventricular ejection
fraction (LVEF) <56% [95]. All patients received DFO at
50–60 mg/kg 12–24 hr/day sc or iv 7 times weekly, com-
bined with either DFP 75 at mg/kg/day (combination
arm) or placebo (DFO monotherapy arm). The primary
endpoint was the change in LVEF by CMR. Improvement
in LVEF was significant in both study arms at 6 and 12
months (p = 0.04), normalizing ventricular function in
9/16 evaluable patients. With combination therapy, the
LVEF increased from 49.9% to 55.2% (+5.3% p = 0.04;
n = 10) at 6 months and to 58.3% at 12 months (+8.4%
p = 0.04; n = 7). With DFO monotherapy, the LVEF in-
creased from 52.8% to 55.7% (+2.9% p = 0.04; n = 6) at
6 months and to 56.9% at 12 months (+4.1% p = 0.04;
n = 4). The LVEF trend did not reach statistical differ-
ence between study arms (p = 0.89). In 2 patients on
DFO monotherapy during the study and in 1 patient
on combined therapy during follow up, heart failure
deteriorated fatally. The study was originally powered
for 86 participants to determine a 5% difference in
LVEF improvement between treatments. The study
was prematurely terminated due to slow recruitment
and with the achieved sample size of 20 patients there
was 80% power to detect an 8.6% difference in EF, which
was not demonstrated. Myocardial T2* improved in both
arms (combination +1.9 ± 1.6 ms p = 0.04; and DFO
monotherapy +1.9 ± 1.4 ms p = 0.04), but with no signifi-
cant difference between treatments (p = 0.65). Liver iron
(p = 0.03) and ferritin (p < 0.001) both decreased signifi-
cantly in only the combination group. The authors con-
cluded that both treatments significantly improved LVEF
and myocardial T2*. Although this is the largest and only
randomized study in patients with LV decompensation,
further prospective evaluation is needed to identify opti-
mal chelation management in these high-risk patients.
Valves
The application of CMR to the assessment of valvular
heart disease continues to increase, [96] particularly in
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appreciation of its complementary roles in relation to
echocardiography, which is commonly the first line in-
vestigative technique.
A novel technique to quantify the instantaneous mitral
regurgitant rate
Rates of mitral regurgitation are known to be variable
through the course of systole. This study set out to
quantify such variation by CMR in 41 patients with mi-
tral regurgitation [99]. Systole was divided equally into
early, mid, and late systolic parts. Aortic flow and left
ventricular stroke volume (LVSV) were plotted against
time, so enabling the regurgitant rate to be calculated
for each third of systole. Variations of mitral regurgitant
rate were found, even among patients with holosystolic
mitral regurgitation jets, highlighting the need to take
temporal variation into consideration.
Discrepancies between cardiovascular magnetic resonance
and Doppler echocardiography in the measurement of
transvalvular gradient in aortic stenosis: the effect of flow
vorticity
This study investigated factors, in aortic stenosis (AS),
that might underlie discrepancies between CMR and
transthoracic echocardiographic (TTE) calculations of
transvalvular mean pressure gradient [100]. The effect
of vorticity, as calculated from CMR velocity acquisi-
tions, was evaluated in 8 volunteers and 60 patients
with AS who had been studied by CMR and TTE.
Strouhal number and energy loss were also calculated
from CMR velocity data. Although some assumptions
underlie the calculations made, the authors concluded
that flow vorticity was a major factor underlying the
discrepancies of MPG measurement between CMR and
TTE.
Early detection of subclinical ventricular deterioration in
aortic stenosis with cardiovascular magnetic resonance
and echocardiography
Aortic stenosis (AS) patients with late gadolinium en-
hancement (LGE) are known to have worse outcome.
Using echocardiography and CMR, the authors investi-
gated whether LGE would be useful to detect left
ventricular (LV) structural and functional abnormal-
ities in AS. Although there was no difference in aortic
valve area between groups, there was a significant
trend towards increasing LV volumes, LV mass, wors-
ening of LV diastolic function with the presence of
LGE and reduced LV ejection fraction, which coincided
with worsening functional capacity. In addition, the
amount of myocardial fibrosis on CMR correlated with
parameters of diastolic elastance and end-systolic elas-
tance. These findings suggest a potential role of CMRfor early detection of subclinical LV structural and
functional deterioration in AS patients [101].
Left ventricular reverse remodeling after transcatheter
aortic valve implantation: a cardiovascular magnetic
resonance study
CMR was used to investigate the degree of left ventricular
mass regression and changes in left ventricular function
six months after transcatheter aortic valve implantation
(TAVI). As previously reported with surgical aortic valve
replacement, left ventricular mass decreased significantly
after six months of follow-up. There was a trend for
improvement in left ventricular ejection fraction. Left ven-
tricular end-diastolic volume and stroke volume did not
change significantly. Based on these findings, significant
left ventricular reverse remodeling is expected to occur six
months after TAVI [102].
Myocardial perfusion
Although myocardial perfusion CMR has been possible
for many years, the clinical sequence and data process-
ing remain variable between centres. Large multicentre
trials are starting to address this issue, [103,104] and
technical advances are constantly being made, [105,106]
with improved understanding of imaging artefacts [107].
The clinical consideration of best application are also
under scrutiny [108,109]. The papers below help to close
the gap between research and clinical practice.
Prognostic value of normal regadenoson stress perfusion
cardiovascular magnetic resonance
Regadenoson is a vasodilator stress agent that selectively
activates the A2A receptor. Compared to adenosine,
regadenoson is easier to administer and results in fewer
side effects. Although extensively studied in patients
undergoing nuclear perfusion imaging (MPI), its use for
perfusion CMR is not well described. The aim of this
study was to determine the prognostic value of a normal
regadenoson perfusion CMR in patients with known or
suspected coronary artery disease [110]. Patients with
known or suspected coronary artery disease were pro-
spectively enrolled to receive perfusion CMR (Philips
1.5 T) with regadenoson. Three short-axis slices of the
left ventricle (LV) were obtained during first pass of
contrast using a hybrid GRE-EPI pulse sequence (0.075
mmol/kg Gadolinium-DTPA-BMA at 4 ml/sec). Imaging
was performed 1 minute after injection of regadenoson
(0.4 mg) and repeated 15 minutes after reversal of
hyperemia with aminophylline (125 mg). Perfusion defects
were documented if they persisted for ≥ 2 frames after
peak enhancement of the LV cavity. CMR was considered
abnormal if there was a resting wall motion abnormality,
decreased LVEF (<40%), presence of LGE, or the presence
of a perfusion defect during hyperemia. All patients were
Pennell et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:100 Page 13 of 29
http://jcmr-online.com/content/16/1/100followed for a minimum of 1 year for major adverse
cardiovascular event (MACE) defined as coronary re-
vascularization, non-fatal myocardial infarction, and
cardiovascular death. 149 patients were included in the
final analysis. Perfusion defects were noted in 43/149
(29%) patients; 59/149 (40%) had any abnormality on
CMR. During the mean follow-up period of 24 ± 9
months, 17/149 (11.4%) patients experienced MACE.
The separation in the survival distributions for those
with perfusion defects and those without perfusion de-
fects was highly significant (log-rank p = 0.0001).
When the absence of perfusion defects was added to
the absence of other resting CMR abnormalities, the
negative predictive value improved from 96% to 99%.
The authors concluded that Regadenoson perfusion
CMR provides high confidence for excellent prognosis
in patients with normal perfusion
Regadenoson and adenosine are equivalent vasodilators
and are superior than dipyridamole- a study of first pass
quantitative perfusion cardiovascular magnetic resonance
Regadenoson, dipyridamole and adenosine are com-
monly used vasodilators in myocardial perfusion imaging
for the detection of obstructive coronary artery disease.
There are few comparative studies of the vasodilator
properties of regadenoson, adenosine and dipyridamole
in humans. The specific aim of this study was to deter-
mine the relative potency of these three vasodilators by
quantifying stress and rest myocardial perfusion in humans
using CMR [111]. Fifteen healthy normal volunteers, with
Framingham score less than 1% underwent vasodilator
stress testing with regadenoson (400 μg bolus), dipyrid-
amole (0.56 mg/kg) and adenosine (140 μg /kg/min) on
separate days. Rest perfusion imaging was performed ini-
tially. Twenty minutes later, stress imaging was performed
at peak vasodilation, i.e. 70 seconds after regadenoson, 4
minutes after dipyridamole infusion and between 3–4 mi-
nutes of the adenosine infusion. Myocardial blood flow
(MBF) in ml/min/g and myocardial perfusion reserve
(MPR) were quantified using a fully quantitative model
constrained deconvolution. Regadenoson produced higher
stress MBF than dipyridamole and adenosine (3.58 vs 2.81
vs 2.78 ml/min/g, p = 0.0009 and p = 0.0008 respectively).
Regadenoson had a much higher heart rate response than
adenosine and dipyridamole respectively (9 5vs 76 vs 86
beats/ minute) When stress MBF was adjusted for heart
rate, there were no differences between regadenoson and
adenosine (37.8 vs 36.6 μl/s/g, p = NS), but differences be-
tween regadenoson and dipyridamole persisted (37.8 vs
32.6 μl/s/g, p = 0.03). The unadjusted MPR was higher
with regadenoson (3.11) when compared with adenosine
(2.7, p = 0.02) and when compared with dipyridamole
(2.61, p = 0.04). Similar to stress MBF, these differences in
MPR between regadenoson and adenosine were abolishedwhen adjusted for heart rate (2.04 vs 2.12, p = NS), but
persisted between regadenoson and dipyridamole (2.04 vs
1.77 , p = 0.07) and between adenosine and dipyridamole
(2.12 vs 1.77, p =0.01). The authors concluded that rega-
denoson and adenosine have similar vasodilator efficacy
and are superior to dipyridamole.
Cost-effectiveness of cardiovascular magnetic resonance
and single-photon emission computed tomography for
diagnosis of coronary artery disease in Germany
Recent studies have demonstrated a superior diagnostic
accuracy of CMR for the detection of coronary artery
disease (CAD). The authors aimed to determine the com-
parative cost-effectiveness of CMR versus single-photon
emission computed tomography (SPECT) [112]. Based on
Bayes' theorem, a mathematical model was developed to
compare the cost-effectiveness and utility of CMR with
SPECT in patients with suspected CAD. Invasive coronary
angiography served as the standard of reference. Effective-
ness was defined as the accurate detection of CAD, and
utility as the number of quality-adjusted life-years
(QALYs) gained. Model input parameters were derived
from the literature, and the cost analysis was con-
ducted from a German health care payer's perspective.
Reimbursement fees represented only a minor fraction
of the total costs incurred by a diagnostic strategy.
Increases in the prevalence of CAD were generally
associated with improved cost-effectiveness and de-
creased costs per utility unit (ΔQALY). By comparison,
CMR was consistently more cost-effective than SPECT,
and showed lower costs per QALY gained. Given a
CAD prevalence of 0.50, CMR was associated with
total costs of €6,120 for one patient correctly diagnosed
as having CAD and with €2,246 per ΔQALY gained versus
€7,065 and €2,931 for SPECT, respectively. Above a
threshold value of CAD prevalence of 0.60, proceeding
directly to invasive angiography was the most cost-
effective approach. The authors concluded that in pa-
tients with low to intermediate CAD probabilities, CMR
is more cost-effective than SPECT. Moreover, lower
costs per utility unit indicate a superior clinical utility of
CMR.
Rapid ungated myocardial perfusion cardiovascular
magnetic resonance: preliminary diagnostic accuracy
The authors describe a rapid ungated radial turboFLASH
saturation recovery myocardial perfusion sequence at 3T
[113]. A hybrid pulse train is used for the saturation
followed by 4 to 5 slices of undersampled radial k-space
image data rapidly acquired. This acquisition is con-
tinuously repeated approximately four times per second
and image reconstruction used an iterative con-
strained method. The ungated perfusion images were
post-processed into ungated, self-gated near systolic
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tested by comparison to quantitative coronary angiog-
raphy in a small cohort of patients with a mix of sinus
rhythm and atrial fibrillation. This simplified ungated
radial dynamic CMR perfusion imaging approach was
shown to give high quality imaging with high diagnostic
accuracy.
Combined measurement of perfusion, venous oxygen
saturation, and skeletal muscle T2* during reactive
hyperemia in the leg
This manuscript describes how a pulsed arterial spin
labelling method for measuring tissue perfusion can be
combined in an interleaved fashion with a multi gradient
echo sequence enabling the simultaneous measurement
of venous oxygen saturation and T2* for BOLD imaging
[114]. The individual methods have been previously
developed and validated and in this work the combined
sequence is compared and validated against the inde-
pendent measurements. The method is applied to the as-
sessment of vascular function by imaging during reactive
hyperaemia both in healthy volunteers and patients with
peripheral artery disease. The novel sequence (given the
new acronym PIVOT) achieves excellent temporal reso-
lution, and preserves good spatial resolution via keyhole
imaging for the oxygenation components.
Hyperemic stress myocardial perfusion cardiovascular
magnetic resonance in mice at 3 Tesla: initial experience
and validation against microspheres
Dynamic first-pass contrast-enhanced myocardial perfu-
sion is the standard CMR method for the estimation of
myocardial blood flow in man, but it is challenging in
rodents because of the high temporal and spatial reso-
lution requirements. Working at 3T, this is the first re-
port on first-pass stress perfusion imaging in mice [115].
The authors determined absolute blood flow at rest and
during dipyridamole stress, as well as perfusion reserve
(2.4 ± 0.5), which agreed with literature values. There
was also close agreement with microsphere validation.
This method has implications for the study of stress-
induced ischemia in murine models.
Oxygenation-sensitive cardiovascular magnetic resonance
Oxygenation-sensitive CMR is a non-contrast technique
that allows the non-invasive assessment of myocardial
oxygenation. It capitalizes on the fact that deoxygenated
hemoglobin in blood can act as an intrinsic contrast
agent, changing proton signals in a fashion that can be
imaged to reflect the level of blood oxygenation. Increases
in oxygen saturation increase the BOLD imaging signal
(T2 or T2*), whereas decreases diminish it. This review
presents the basic concepts and limitations of the BOLD
technique, and summarizes the preclinical and clinicalstudies in the assessment of myocardial oxygenation with
a focus on recent advances [116]. Finally, it provides
future directions and a brief look at emerging techniques
of this evolving CMR field.
Acute and chronic coronary artery disease
CMR is invaluable to the study of patients with ischae-
mic heart disease and has made a major impact on this
field and is now widely used to delineate myocardial
infarction, [117] although more recently non-contrast
techniques to detect infarction have been described
[118,119]. The use of native contrast techniques to de-
fine myocardial edema, [120,121] myocardium at risk,
[122] myocardial hemorrhage, [123,124] and micro-
vascular obstruction, [125] has also grown greatly.
Work has moved on to evaluating the relation between
myocardial damage and aspects of myocardial function
such as dyssynchrony, [126,127] remodelling, [128,129]
healing, [130] and novel treatments [131,132]. The pa-
pers below show how CMR can be used in a number
of ways to characterize acute and chronic coronary
disease.
Incremental value of cardiovascular magnetic resonance
over echocardiography in the detection of acute and
chronic myocardial infarction
The diagnostic accuracy of echocardiography in detect-
ing ST elevation myocardial infarction was compared to
CMR in both acute and chronic stages. Sensitivity of
echocardiography to detect acute and chronic myocar-
dial infarctions based on the presence of regional wall
motion abnormalities was 78.7% and 61.3%, respectively;
specificity was 80.6% in both settings. Echocardiography
was therefore more sensitive to detect acute versus
chronic infarctions. Undetected myocardial infarctions
were smaller, less extensive and less transmural, associ-
ated with non-anterior localization and higher ejection
fraction as compared to detected myocardial infarctions
[133].
Scar extent evaluated by late gadolinium enhancement
CMR: a powerful predictor of long term appropriate ICD
therapy in patients with coronary artery disease
The purpose of this study was to compare different
methods of quantifying myocardial scar extent and their
value as predictors of appropriate ICD therapy in patients
with coronary artery disease. Total myocardial scar and
percentage of myocardial scar as determined by late
gadolinium enhancement were found to be predictors of
appropriate discharge. Four different measures of scar
transmurality were assessed: 1) “scar transmurality area
based”; 2) “scar transmurality line based”; 3) “weighted
infarct transmurality”, and; 4) “spatial maximal scar
transmurality”. There was some variation between the
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the number of events was relatively small [134]. Further
studies are needed to obtain a consensual method of
determining scar transmurality.Comparison of diffusion-weighted with T2-weighted
imaging for detection of edema in acute myocardial
infarction
The aim of this study was to assess myocardial edema
with diffusion weighted imaging (DWI) in patients
with acute myocardial infarction (AMI) and to com-
pare it with a T2 turbo inversion recovery, black blood
sequences - TIRM [135]. The study included 91 acute
and post STEMI patients. They applied a qualitative
and quantitative image analysis. The qualitative ana-
lysis consisted of evaluation of the quality of blood
suppression, presence of artifacts and occurrence of
high signal (edema) areas. On the basis of edema
detection in AMI and control (post STEMI) group, the
sensitivity and specificity of TIRM and DWI were
determined. Two contrast to noise ratios (CNR) were
calculated: CNR1 - the contrast between edema and
healthy myocardium and CNR2 - the contrast between
edema and intraventricular blood pool. The area of
edema was measured for both TIRM and DWI
sequences and compared with the infarct size in LGE
images. The study indicated that diffusion weighted
imaging detects areas of increased myocardial signal in
patients with acute myocardial infarction with high
sensitivity and specificity (83.1% and 90.0% respect-
ively). DWI may also be used to differentiate chronic
from acute injury.Scar heterogeneity on cardiovascular magnetic resonance
as a predictor of appropriate implantable cardioverter
defibrillator therapy
Using a similar design to the previous work, this study
evaluates heterogeneous scar area in predicting appro-
priate ICD therapy for primary prevention of sudden
cardiac death. Scar size was determined using thresholds
of 4 and 6 standard deviations (SD) above the normal
myocardium. Three different criteria were used to define
heterogeneous scar area: the region between 2SD and
4SD (HSA2-4SD), between 2SD and 6SD (HSA2-6SD), and
between 4SD and 6SD (HSA4-6SD). The study showed
that scar size was similar in ICD therapy and non-ICD
therapy groups. However, HSA2-4SD and HSA4-6SD were
significantly larger in the ICD therapy group. On multi-
variable analysis, HSA2-4SD was the only independent
predictor of ICD therapy. If confirmed in larger series,
heterogeneous scar area may be used for risk stratifica-
tion of sudden cardiac death [136].Multi-contrast late enhancement CMR determined gray
zone and papillary muscle involvement predict appropriate
ICD therapy in patients with ischemic heart disease
Myocardial infarct heterogeneity was associated with
appropriate ICD therapy in this cohort of patients with
ischemic heart disease. Unlike the previous report, the
gray zone area was defined by a novel multi-contrast
late enhancement technique, which was more sensitive
to predict appropriate ICD therapy when compared to
the standard inversion recovery gradient echo sequence.
Only the proportion of peri-infarct gray zone and papillary
muscle infarct scores were significantly associated with ap-
propriate ICD therapy for ventricular arrhythmias [137].
The effect of microvascular obstruction and intramyocardial
hemorrhage on contractile recovery in reperfused
myocardial infarction: insights from cardiovascular
magnetic resonance
The authors investigated the role of microvascular ob-
struction (MO) and intramyocardial hemorrhage (IMH)
in the recovery of contractility of the infarcted myocar-
dium. Overall, infarct zone strain recovered with time. By
day 90, infarcts with MO had more attenuated strain in all
myocardial layers compared to infarcts without MO; those
with IMH were attenuated further. Infarct transmurality
did not correlate with strain. On multivariable logistic
regression, MO and IMH were the only independent
predictors of attenuated 90-day infarct zone strain [138].
Reduced recovery of contractility may be a harbinger of
adverse left ventricular remodeling and prognosis associ-
ated with MO and IMH, irrespective of infarct size.
Inter-observer agreement and diagnostic accuracy of
myocardial perfusion reserve quantification by
cardiovascular magnetic resonance at 3 Tesla in
comparison to quantitative coronary angiography
Myocardial perfusion reserve by CMR has shown to cor-
relate with invasive evaluation of coronary artery disease
and to yield good interobserver agreement at 1.5 Tesla.
The aim of this study was to evaluate these parameters at
3 Tesla. Interobserver agreement was high for all myocar-
dial perfusion territories. The diagnostic accuracy com-
pared to coronary angiography was good for the RCA and
LAD territories, but only moderate for the LCX territory
[139]. This difference in accuracy may be explained by the
lower signal-to-noise ratio in the thinner lateral wall and
distance to the surface coils.
Relationship between coronary flow reserve evaluated by
phase-contrast cine cardiovascular magnetic resonance
and serum eicosapentaenoic acid
Long-term intake of long-chain n-3 polyunsaturated fatty
acids (PUFAs), especially eicosapentaenoic acid (EPA), is
associated with a low risk for cardiovascular disease. This
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serve (CFR) and serum EPA in patients with coronary
artery disease. Breath-hold phase-contrast cine CMR
images of the coronary sinus (CS) were acquired to
assess blood flow of the CS both at rest and during
adenosine infusion. Serum EPA positively correlated
with CFR. Multivariate analysis revealed EPA to be an
independent predictor of preserved CFR [140]. These
findings suggest that improved endothelial function
might be an important mechanism through which n-3
PUFAs prevent cardiovascular events.
Variability and homogeneity of cardiovascular magnetic
resonance myocardial T2-mapping in volunteers
compared to patients with edema
T2-mapping is a promising tool for detecting and quanti-
fying myocardial edema. This study evaluated the repro-
ducibility and variability of myocardial T2 mapping in
healthy volunteers and in patients with acute myocardial
injury. Mapping revealed increased T2 in all patients with
edema, and showed high intraobserver and interobserver
variability, suggesting that this technique is both feasible
and reproducible. However, in the volunteer group, global
myocardial T2 differed slightly depending on the sequence
and image orientation used, the latter likely due to partial
volume and residual motion [141].
Highly automatic quantification of myocardial oedema in
patients with acute myocardial infarction using bright
blood T2-weighted CMR
Some of the major challenges facing myocardial T2
quantification include manual delineation of the left
ventricular boundaries and segmentation of myocardial
edema. The authors propose a highly automatic frame-
work for quantifying myocardial edema from bright
blood T2-weighted CMR. The new method was tested
in patients with acute myocardial infarction. The results
showed accurate delineation of the edematous areas
compared to manual quantification. Although the frame-
work appears straightforward, future validation is needed
in animal experiments and in larger clinical cohorts [142].
Intra-thoracic fat volume is associated with myocardial
infarction in patients with metabolic syndrome
Visceral adiposity is increased in patients with Metabolic
Syndrome (MetS). The authors evaluated the associations
between intra-thoracic fat volume (ITFV) and myocardial
infarction in 94 subjects with MetS [143]. They found that
ITFV was elevated in patients with MetS and was further
increased in those with evidence of prior ischemic myo-
cardial injury, as assessed by subendocardial LGE. They
propose ITFV as a valuable marker of myocardial infarc-
tion risk in MetS.At-risk but viable myocardium in a large animal model of
non ST-segment elevation acute coronary syndrome:
cardiovascular magnetic resonance with ex vivo validation
Patients with NSTEMI have variable degrees of salvage-
able myocardium. The authors used a canine model of
partial coronary stenosis combined with pacing to induce
a reversible degree of ischemia [144]. Myocardial T2 was
assessed as an indicator of at-risk myocardium. Ischemic,
but not irreversibly injured (no LGE), myocardium
showed significantly higher T2 than remote myocardium.
T2-CMR of salvageable myocardium is an attractive bio-
marker for preclinical and clinical studies of NSTEMI.
Gadolinium use in CMR
The additive information that can be gained in CMR by
the administration of gadolinium based contrast agents is
substantial, and these are being applied in new situations.
There is now general awareness of the rare but potentially
serious complication of nephrogenic systemic fibrosis
(NSF) observed following administration of some earlier
gadolinium agents, notably in the presence of significant
renal impairment [145]. This had led to guidelines re-
garding the use of these agents and surveys of their use
[146,147].
Effectiveness of late gadolinium enhancement to improve
outcomes prediction in patients referred for cardiovascular
magnetic resonance after echocardiography
The authors studied whether CMR improves outcomes
prediction after contemporaneous echocardiography in a
prospective study of 444 patients clinically referred for
CMR [148]. The ejection fraction better predicted mor-
tality (30 deaths at median 0.8 years) than echo ejection
fraction. Furthermore, CMR with LGE further improved
risk stratification for death beyond ejection fraction and
predicted transplant free survival after adjustment for
age, gender, wall motion and ejection fraction. This
paper demonstrates the incremental added prognostic
value of CMR in patients referred for CMR in addition
to echocardiography.
Evaluation of current algorithms for segmentation of scar
tissue from late Gadolinium enhancement cardiovascular
magnetic resonance of the left atrium: an open-access
grand challenge
CMR continues to play an increasingly important role for
quantifying LA fibrosis and scar before and after ablation
procedures for AF. A standardised evaluation benchmark-
ing framework is presented for algorithms segmenting
fibrosis and scar from LGE CMR images [149]. The aim is
to guide treatment stratification of patients with atrial fib-
rillation (AF) and for assessment of treatment after radio
frequency catheter ablation (RFCA). The framework en-
ables comparison of scar segmentation algorithms in the
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pares eight algorithms that previously have only been
tested on centre- and vendor-specific images. The pro-
posed framework evaluated 8 different algorithms and
measured their performance on a common scale. Refer-
ence standards for evaluation were established. Follow-
ing evaluation, no algorithm was deemed clearly better
than the others. This study highlights the opportunity
for future development of algorithms however robust
benchmarking is important.
Myocardial mechanics
Measuring cardiac function is a fundamental for CMR.
Myocardial tagging remains a source of research, [150]
and at 3T has attracted interest, [151,152] partly because
of the improved tag persistence with longer T1. Newer
techniques have also been reported in humans, [153] in-
cluding accelerated 3D techniques [154]. Feature tracking
has become an area of active interest with development of
simple to use software that can be used post-hoc on
simple cines, [155,156] however the lack of validation at
segmental level remains an issue. The papers below pursue
novel aspects of cardiac function.
Global and regional left ventricular myocardial deformation
measures by magnetic resonance feature tracking in
healthy volunteers: comparison with tagging and
relevance of gender
Feature tracking post processing of SSFP cines of 145
healthy volunteers was used to record LV deformation
parameters [157]. In 20 volunteers, values were also
obtained by CMR tagging for comparison of global but
not segmental measurements. For the globally averaged
measurements of strain, only those measured circumfer-
entially in short axis slices showed reasonably good
levels of agreement between FT and tagging (limits of
agreement −0.06 to 0.04). Longitudinal strain showed
wide limits of agreement (−0.16 to 0.03) with evidence
of overestimation of strain by FT relative to tagging as
the mean of both measures increased. Radial strain was
found to be systematically overestimated by FT relative
to tagging with relatively wide limits of agreement.
Provisional ranges of FT deformation parameters at
global, regional and segmental levels were reported,
showing evidence of variation with gender and myo-
cardial region in the volunteers studied, although the
segmental values had not been validated by comparison
with measurements by tagging.
Longitudinal strain from velocity encoded cardiovascular
magnetic resonance: a validation study
Heiberg and colleagues measured regional wall strain
from long axis turbo field echo (TFE) velocity encoded
CMR in three long axis planes in 36 healthy volunteersand 10 patients with recent myocardial infarction [158].
Fast field echo (FFE) cines were acquired in the same
planes to help delineate myocardial borders. A phantom
experiment was performed to use optical tracking of
elastic deformation as an independent gold standard for
comparison. Excellent agreement was found between
longitudinal strain measured by optical tracking and lon-
gitudinal strain measured with TFE velocity encoding.
Mean longitudinal strain in patients was less than that
in volunteers, and strain in infarcted regions, less than
in remote areas. The authors concluded that the tech-
nique could quantify longitudinal strain and regional
myocardial wall function and report normal values by
the method.
Inter-study reproducibility of cardiovascular magnetic
resonance tagging
The test-retest reliability of the measurement of regional
myocardial function by CMR tagging by spatial modula-
tion of magnetization, analysed using harmonic phase
(HARP), was investigated in 25 participants [159]. The
role of altered slice orientation on strain measurements
was investigated. The intraobserver and interobserver
reproducibility of all strain and torsion parameters
measured was reported to be excellent. Variations of
endocardial circumferential strain due to altered slice
orientation were found to be negligible compared to
those doe to different slice location.
Efficient and reproducible high resolution spiral myocardial
phase velocity mapping of the entire cardiac cycle
This study demonstrates the feasibility of a novel myo-
cardial velocity acquisition technique [160]. The image
acquisition method described uses a spiral k space
coverage to provide high temporal and spatial resolution
cardiac motion images that further our general know-
ledge about myocardial motion mechanics. The method
also, for the first time, uses retrospective cardiac gating
which enables the atrial systolic motion to be measured.
Good reproducibility of scans in the same subjects is also
reported. The authors concluded that their retrospectively
gated spiral phase velocity mapping sequence is an effi-
cient and reproducible method of acquiring 3-directional,
high resolution velocity data throughout the entire cardiac
cycle, including atrial systole.
Feature tracking measurement of dyssynchrony from
cardiovascular magnetic resonance cine acquisitions:
comparison with echocardiographic speckle tracking
This paper reports quantification of LV dyssynchrony by
feature tracking post processing of routine CMR cine
acquisitions (FT-CMR) in comparison to speckle tracking
echocardiography in 72 consecutive patients who also had
echocardiography, analysed by speckle tracking [161]. The
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chrony which, at least for the patients with more marked
dyssynchrony, showed reasonable agreement with those
from speckle tracking echocardiography. The clinical use-
fulness of the method, for example in predicting prognosis
in CRT patients, remains to be investigated.
Relationship of phasic left atrial volume and emptying
function to left ventricular filling pressure: a
cardiovascular magnetic resonance study
In this study, CMR was performed in 41 patients on the
same day as clinically indicated left heart catheterization
[162]. This allowed left atrial volume (LAV) and emptying
fraction (LAEF), measured by the biplane area and length
method, to be related to left ventricular end diastolic pres-
sure (LVEDP). Average LV ejection fraction was 49 ± 16%
ranging from 10% to 74% and LVEDP by catheterization
14 ± 8 mmHg ranging from 4 mmHg to 32 mmHg.
Of those analysed, increased LAVmin and decreased
LAEFTotal were found to the most effective identifiers of
LVEDP.
Novel insight into the detailed myocardial motion and
deformation of the rodent heart using high-resolution
phase contrast cardiovascular magnetic resonance
Phase contrast velocimetry cardiovascular magnetic res-
onance (PC-CMR) is a powerful tool for assessment of
in vivo motion of the myocardium. In this study, the
authors demonstrate in the rat heart that PC-CMR can
measure in vivo circumferential strain in addition to
myocardial motion [163]. This work provides a refined
tool for longitudinal assessment of regional function in
rodents with a high level of detail.
Reproducibility of cine displacement encoding with
stimulated echoes (DENSE) cardiovascular magnetic
resonance for measuring left ventricular strains, torsion,
and synchrony in mice
Advanced measures of cardiac function, beyond LV
volumes and ejection fraction, are increasingly important
due to their superior diagnostic and predictive capabilities.
Cine DENSE CMR is a powerful method in this regard,
and the authors examined its reproducibility in mice
[164]. They found measures of strains, torsion and syn-
chrony to be highly reproducible. However, myocardial
twist angles were not reproducible, and they recom-
mend that future studies should instead report torsion.
Obesity reduces left ventricular strains, torsion, and
synchrony in mouse models: a cine displacement encoding
with stimulated echoes (DENSE) cardiovascular magnetic
resonance study
Obesity is now common, and it increases cardiovascular
mortality; however, the effect of obesity on cardiac functionin animal models is not well-defined. Studying mice
randomized to a high-fat or low-fat diet at 7 T using a
cine DENSE protocol, the authors found an increase in
left ventricular mass by 15%, a 40% reduction in subepicar-
dial circumferential strain, a 53% reduction in radial strain,
a 34% decrease in peak torsion, as well as significant dys-
synchrony in obese mice [165]. This model can serve to
investigate strategies to protect the heart in obesity.
Ventricular & Atrial volumes and motion
Given increasing availability and uptake of CMR, it is
ever more important to determine the appropriate appli-
cation of CMR derived values to clinical use. Although
there is good correlation between ejection fraction mea-
sured by CMR and echocardiography, the values are not
interchangeable. Consequently, where an evidence base
has been established in one modality, the threshold value
cannot necessarily accurately and reliably be transferred
across modalities [166]. CMR volumes can guide prognosis
[167]. Newer techniques still not included in clinical prac-
tice include myocardial tissue phase mapping [168,169].
Atlas-based analysis of cardiac shape and function:
correction of regional shape bias due to imaging
protocol for population studies
The Cardiac Atlas Project is a worldwide consortium
seeking to pool cardiac imaging data in a standardized
manner from multiple studies to facilitate meta-analyses
[170]. Atlas-based analysis allows quantification of shape
and motion differences between disease groups and
normal subjects. However, apparent shape differences
may arise from differences of imaging protocol between
studies. This study used a mathematical model describing
regional wall motion and ventricular shape to establish a
coordinate system registered to the cardiac anatomy [171].
The model was applied to data from studies using either
steady state free precession or gradient recalled echo
CMR. Shape bias attributable to the acquisition method
was effectively removed using the atlas-based transform-
ation, generated from a set of 46 volunteers who had been
imaged by both methods. This allowed direct comparison
of regional wall motion abnormalities between differently
imaged cohorts.
Evaluation of left ventricular diastolic function by fractional
area change using cine cardiovascular magnetic resonance:
a feasibility study
This study of LV diastolic function was based on CMR
fractional area change (FAC) measured from mid short
axis cines in 59 patients compared with echocardio-
graphic transmitral and tissue Doppler indices [172].
The CMR diastolic index (%FAC during the first 30% of
diastole) decreased with worsening diastolic dysfunction.
It was lower (p < 0.0001) in patients classed by echo as
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filling (25.4 ± 5.6) and restrictive filling (9.5 ± 1.5),
compared to those with normal diastolic function
(67.7 ± 10.8). It correlated positively with early diastolic tis-
sue Doppler mitral annular velocity (r = 0.75, p < 0.0001).
Cardiac steatosis and left ventricular function in men with
metabolic syndrome
Accumulation of fat around visceral organs may have
detrimental effects; lipid oversupply to cardiomyocytes
may lead to lipotoxicity, which has been associated with
impaired left ventricular function. The authors studied
men with metabolic syndrome and those without, using
CMR and 1H-MRS. They found greater fat deposits in
metabolic syndrome, and the amount of epicardial and
pericardial fat correlated inversely with LV diastolic func-
tion; however, myocardial triglyceride content did not
[173]. This study shows that the relationships amongst fat
depots, cardiomyocyte fat accumulation and LV function
are complex and merit further study.
Reference right atrial dimensions and volume estimation
by steady state free precession cardiovascular magnetic
resonance
CMR is the standard for estimating the size of the
cardiac chambers. This study defines normal ranges for
right atrial dimensions and volumes adjusted to age,
gender, and body surface area. It also provides the best
predictors of right atrial enlargement from two-
dimensional measurements [174].
ECG-based gating in ultra high field cardiovascular
magnetic resonance using an independent component
analysis approach
This study investigated a particular problem for CMR in
the small but growing number of centres investigating
the applicability of operating at 7T [175]. The manuscript
described a novel approach to ECG triggering using a 12-
lead ECG system with Independent Component Analysis
(ICA). This is a real problem where a good solution would
be worth finding and the authors demonstrated that their
ICA method outperformed the state-of-the-art VCG-
based technique in this challenging environment.
High spatial and temporal resolution retrospective cine
cardiovascular magnetic resonance from shortened free
breathing real-time acquisitions
This manuscript describes the development of a method
for high quality cine imaging of the heart during free
breathing [176]. The approach used a novel retrospective
reconstruction scheme which was shown to shorten the
required acquisition. The reconstruction algorithm em-
ploys non-rigid registration to remove respiratory motion
and SPIRiT non-linear reconstruction with temporalregularization to fill in missing data. The resulting cine
loops have high spatial and temporal resolution and
perform well for volumetric measurement when com-
pared to conventional breath-hold approaches.
Fast and fully automatic calibration of frequency offset
for balanced steady-state free precession cardiovascular
magnetic resonance at 3.0 Tesla
This paper describes a novel automatic frequency scout-
ing procedure designed for balanced SSFP imaging, es-
pecially at higher field strengths [177]. The method uses
a low flip angle balanced SSFP scan to generate images
at various frequency offsets, and then uses an automated
algorithm to find the approximate optimal frequency.
The method was assessed with various breath-hold and
non-breath-hold approaches to recommend the best
protocol to use in practice. The authors conclude that
this fully automatic method could greatly reduce dark-
band artifacts in bSSFP images and facilitate clinical
cardiac MR routines at 3T.
Cardiac-respiratory self-gated cine ultra-short echo time
(UTE) cardiovascular magnetic resonance for assessment
of functional cardiac parameters at high magnetic fields
This paper performs a careful evaluation on an Ultra-
short TE (UTE) self-navigated approach to cardiac im-
aging on a 9.4Tesla mouse scanner [178]. The authors
propose that the UTE sequence overcomes flow and
electrocardiogram-trigger artifacts. The results dem-
onstrate that image artefacts are reduced with this
method, but SNR is also. By all presented metrics the
UTE approach appeared to be more robust. The au-
thors conclude the method to be a powerful alternative
for the assessment of cardiac function at high magnetic
fields.
Evaluation of a subject specific dual-transmit approach
for improving B1 field homogeneity in cardiovascular
magnetic resonance at 3T
Dual source parallel transmit has now been implemented
on a large number of CMR scanners worldwide. This
manuscript describes a study to investigate B1 shimming
on a parallel transmit system for cardiac cine imaging
[179]. In vivo shimming results are compared with body
type, as characterized by BMI, BSA, and AP/RL. Results
suggested that in the absence of RF shimming, local B1
field homogeneity does not depend on body type. How-
ever, cardiac B1 field homogeneity can be significantly
improved by performing local RF shimming with 2 inde-
pendent RF-transmit channels. The results therefore
indicated the need for subject-specific RF shimming.
Further work is required to establish the impact of these
methods.
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using balanced SSFP and 40 ms resolution
This manuscript describes the implementation and early
clinical testing of a radial balanced SSFP acquisition with
a regularized image reconstruction at 1.5T [180]. The
study describes interesting, original and potentially im-
portant methods as it demonstrates ungated acquisi-
tions acquired in an ultrasound fashion to overcome
gating issues, observe beat-to-beat variations, and re-
duce scan time. Abnormalities in the cardiac cycle
such as extra-systolic contractions are clearly visible in
1D projections. At present the reconstruction times
are limiting for true real-time but in the future the
methods are likely to be important for truly interactive
scanning.
Varia
There are always papers which do not fall into simple cat-
egories. This section pulls together such varia which has
included reviews, [181-183] safety, [184,185] society and
registry reports, [186] and novel, or unusual techniques.
Moderate intensity supine exercise causes decreased
cardiac volumes and increased outer volume variations: a
cardiovascular magnetic resonance study
The effects on left and right ventricular (LV, RV) volumes
during physical exercise remain controversial. Further-
more, no previous study has investigated the effects of
exercise on longitudinal contribution to stroke volume
(SV) and the outer volume variation of the heart. The
aim of this study was to determine if LV, RV and total
heart volumes (THV) as well as cardiac pumping mech-
anisms change during physical exercise compared to
rest using CMR [187]. 26 healthy volunteers (6 women)
underwent CMR at rest and exercise. Exercise was per-
formed using a custom built ergometer for one-legged
exercise in the supine position during breath hold
imaging. Cardiac volumes and atrio-ventricular plane
displacement were determined. Heart rate (HR) was
obtained from ECG. HR increased during exercise
from 60±2 to 94±2 bpm, (p<0.001). LVEDV remained
unchanged (p=0.81) and LVESV decreased with −9±18%
(p<0.05) causing LVSV to increase with 8±3% (p<0.05).
RVEDV and RVESV decreased by −7±10% and −24±14%
respectively, (p<0.001) and RVSV increased 5±17% during
exercise although not statistically significant (p=0.18).
Longitudinal contribution to RVSV decreased during
exercise by −6±15% (p<0.05) but was unchanged for LVSV
(p=0.74). THV decreased during exercise by −4±1%,
(p<0.01) and total heart volume variation (THVV) in-
creased during exercise from 5.9±0.5% to 9.7±0.6%
(p<0.001). The authors concluded that cardiac volumes
and function are significantly altered during supine phys-
ical exercise. THV becomes significantly smaller due todecreases in RVEDV whilst LVEDV remains unchanged.
THVV and consequently radial pumping increases during
exercise which may improve diastolic suction during the
rapid filling phase
Standardized cardiovascular magnetic resonance (CMR)
protocols 2013 update.
This document is an update to the 2008 publication of the
Society for Cardiovascular Magnetic Resonance (SCMR)
Board of Trustees Task Force on Standardized Protocols
[188]. Since the time of the original publication, 3 add-
itional task forces (Reporting, Post-Processing, and
Congenital Heart Disease) have published documents
that should be referred to in conjunction with the
present document. The section on general principles
and techniques has been expanded as more of the
techniques common to CMR have been standardized.
There is still a great deal of development in the area of
tissue characterization/mapping, so these protocols
have been in general left as optional. The authors hope
that this document continues to standardize and sim-
plify the patient-based approach to clinical CMR. It
will be updated at regular intervals as the field of CMR
advances.
Impact of cardiovascular magnetic resonance on
management and clinical decision-making in
heart failure patients
CMR can provide important diagnostic and prognostic
information in patients with heart failure. However, in
the current health care environment, use of a new
imaging modality like CMR requires evidence for direct
additive impact on clinical management. The authors
evaluated the impact of CMR on clinical management
and diagnosis in patients with heart failure [189]. 150
consecutive patients with heart failure and an ejection
fraction ≤ 50% referred for CMR were prospectively
studied. Definitions for "significant clinical impact" of
CMR were pre-defined and collected directly from
medical records and/or from patients. Categories of
significant clinical impact included: new diagnosis,
medication change, hospital admission/discharge, as
well as performance or avoidance of invasive procedures
(angiography, revascularization, device therapy or biopsy).
Overall, CMR had a significant clinical impact in 65% of
patients. This included an entirely new diagnosis in 30%
of cases and a change in management in 52%. CMR
results directly led to angiography in 9% and to the per-
formance of percutaneous coronary intervention in 7%. In
a multivariable model that included clinical and imaging
parameters, presence of late gadolinium enhancement
(LGE) was the only independent predictor of "significant
clinical impact" (OR 6.72, 95% CI 2.56-17.60, p=0.0001).
The authors concluded that CMR made a significant
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and diagnosis in 65% of heart failure patients. This addi-
tive impact was seen despite universal use of prior echo-
cardiography in this patient group. The presence of LGE
was the best independent predictor of significant clinical
impact following CMR. An erratum was also published
[190].
Highlights of the 16th annual scientific sessions of the
society for cardiovascular magnetic resonance
The 16th Annual Scientific Sessions of the Society for
Cardiovascular Magnetic Resonance (SCMR) took place
in San Francisco, USA at the end of January 2013. With
a faculty of experts from across the world, this congress
provided a wealth of insight into cutting-edge research
and technological development. This review article
provides a highlight of what represented the most
significant advances in the field of CMR during this
year's meeting [191].
Quality assessment of cardiovascular magnetic resonance
in the setting of the European CMR registry: description
and validation of standardized criteria
CMR has become an important diagnostic imaging mo-
dality in cardiovascular medicine. However, insufficient
image quality may compromise its diagnostic accuracy.
This paper describes and validates standardized criteria
to evaluate a) cine steady-state free precession (SSFP), b)
late gadolinium enhancement (LGE), and c) stress first-
pass perfusion images [192]. These criteria will serve for
quality assessment in the setting of the Euro-CMR regis-
try. Thirty-five qualitative criteria were defined (scores
0–3) with lower scores indicating better image quality.
In addition, quantitative parameters were measured
yielding 2 additional quality criteria, i.e. signal-to-noise
ratio (SNR) of non-infarcted myocardium (as a measure
of correct signal nulling of healthy myocardium) for
LGE and % signal increase during contrast medium first-
pass for perfusion images. These qualitative and quanti-
tative criteria were assessed in a total of 90 patients (60
patients scanned at our own institution at 1.5T (n=30)
and 3T (n=30) and in 30 patients randomly chosen from
the Euro-CMR registry examined at 1.5T). Analyses
were performed by 2 SCMR level-3 experts, 1 trained
study nurse, and 1 trained medical student. The global
quality score was 6.7±4.6 (n=90, mean of 4 observers,
maximum possible score 64), range 6.4-6.9 (p=0.76 be-
tween observers). It ranged from 4.0-4.3 for 1.5T
(p=0.96 between observers), from 5.9-6.9 for 3T (p=0.33
between observers), and from 8.6-10.3 for the Euro-CMR
cases (p=0.40 between observers). The inter- (n=4) and
intra-observer (n=2) agreement for the global quality
score, i.e. the percentage of assignments to the same qual-
ity tertile ranged from 80% to 88% and from 90% to 98%,respectively. The agreement for the quantitative assess-
ment for LGE images (scores 0–2 for SNR <2, 2–5, >5,
respectively) ranged from 78-84% for the entire popula-
tion, and 70-93% at 1.5T, 64-88% at 3T, and 72-90% for
the Euro-CMR cases. The agreement for perfusion images
(scores 0–2 for %SI increase >200%, 100%-200%,<100%,
respectively) ranged from 81-91% for the entire popula-
tion, and 76-100% at 1.5T, 67-96% at 3T, and 62-90% for
the Euro-CMR registry cases. The intra-class correlation
coefficient for the global quality score was 0.83. The au-
thors concluded that the criteria for the assessment of
CMR image quality are robust with a good inter- and
intra-observer agreement. Further research is needed to
define the impact of image quality on the diagnostic and
prognostic yield of CMR studies.
Cost-effectiveness analysis for imaging techniques with a
focus on cardiovascular magnetic resonance
With the need for healthcare cost-containment, increased
scrutiny will be placed on new medical therapeutic or
diagnostic technologies. Several challenges exist for a new
diagnostic test to demonstrate cost-effectiveness. New
diagnostic tests differ from therapeutic procedures due to
the fact that diagnostic tests do not generally directly
affect long-term patient outcomes. Instead, the results of
diagnostic tests can influence management decisions for
patients and by this route, diagnostic tests indirectly affect
long-term outcomes. The benefits from a specific diag-
nostic technology depend therefore not only on its per-
formance characteristics, but also on other factors such
as prevalence of disease, and effectiveness of existing
treatments for the disease of interest. We review the
concepts and theories of cost-effectiveness analyses
(CEA) as they apply to diagnostic tests in general. In
this paper, the limitations of CEA across different study
designs and geographic regions are discussed, and the
strengths and weakness of the existing publications are
examined where CMR was the focus of CEA compared
to other diagnostic options [193].
Imaging in population science: cardiovascular magnetic
resonance in 100,000 participants of UK Biobank -
rationale, challenges and approaches
UK Biobank is a prospective cohort study with 500,000
participants aged 40 to 69. Recently an enhanced imaging
study received funding. CMR will be part of a multi-
organ, multi-modality imaging visit in 3–4 dedicated UK
Biobank imaging centres that will acquire and store im-
aging data from 100,000 participants (subject to successful
piloting). In each of UK Biobank's dedicated bespoke
imaging centres, it is proposed that 15–20 participants will
undergo a 2 to 3 hour visit per day, seven days a week
over a period of 5–6 years. The imaging modalities will
include brain MRI at 3 Tesla, CMR and abdominal MRI
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fully selected protocols. We reviewed the rationale, chal-
lenges and proposed approaches for concise phenotyping
using CMR on such a large scale. Here, we discuss the
benefits of this imaging study and review existing and
planned population based cardiovascular imaging in pro-
spective cohort studies. The study will evaluate the CMR
protocol, feasibility, process optimisation and costs [194].
Procedures for incidental findings, quality control and
data processing and analysis are also presented. As is the
case for all other data in the UK Biobank resource, this
database of images and related information will be made
available through UK Biobank's Access Procedures to
researchers (irrespective of their country of origin and
whether they are academic or commercial) for health-
related research that is in the public interest.
Cardiovascular magnetic resonance artefacts
The multitude of applications offered by CMR make it
an increasing popular modality to study the heart and
the surrounding vessels. Nevertheless the anatomical
complexity of the chest, together with cardiac and re-
spiratory motion, and the fast flowing blood, present
many challenges which can possibly translate into im-
aging artefacts. The literature is wide in terms of papers
describing specific MR artefacts in great technical detail.
This review attempts to summarise, in a language
accessible to a clinical readership, some of the most
common artefacts found in CMR applications [195]. It
begins with an introduction of the most common pulse
sequences, and imaging techniques, followed by a brief
section on typical cardiovascular applications. This
leads to the main section on common CMR artefacts
with examples, a short description of the mechanisms
behind them, and possible solutions.
Standardized image interpretation and post processing
in cardiovascular magnetic resonance: Society for
Cardiovascular Magnetic Resonance (SCMR) board of
trustees task force on standardized post processing
With mounting data on its accuracy and prognostic
value, CMR is becoming an increasingly important diag-
nostic tool with growing utility in clinical routine. Given
its versatility and wide range of quantitative parameters,
however, agreement on specific standards for the inter-
pretation and post-processing of CMR studies is re-
quired to ensure consistent quality and reproducibility
of CMR reports. This document addresses this need by
providing consensus recommendations developed by
the Task Force for Post Processing of the Society for
Cardiovascular MR (SCMR) [196]. The aim of the task
force is to recommend requirements and standards for
image interpretation and post processing enabling
qualitative and quantitative evaluation of CMR images.Furthermore, pitfalls of CMR image analysis are discussed
where appropriate.
European cardiovascular magnetic resonance (EuroCMR)
registry – multi national results from 57 centers in 15
countries
This paper reports 27,000 patients consecutively enrolled
in the multi-national EuroCMR registry, in which 34%
of CMRs were indicated for risk stratification in sus-
pected ischaemic heart disease, 32% for myocarditis or
cardiomyopathy, and 15% for viability [197]. In 98% CMR
was diagnostic and it impacted patient management in 62.
CMR was safe. Interim analysis underscores the prognos-
tic value of routinely available clinical CMR; a normal
stress CMR was associated with a 1% risk per year for ad-
verse events, and a LGE negative CMR with 2.7% risk per
year of adverse events in hypertrophic cardiomyopathy.
Cardiovascular magnetic resonance with an MR compatible
pacemaker
FDA guidelines for MRI-conditional pacemakers preclude
placing the heart at the center of the magnet’s bore and
consequently the acquisition of CMR studies. In this
manuscript, the authors describe a CMR protocol for pa-
tients with a Revo pacemaker system while operating
within FDA guidelines, and the first CMR case in a patient
with a Revo MRI-conditional pacing system despite pos-
ition constraints [198].
Magnetic resonance of the heart in a muscular dystrophy
patient with an MR conditional ICD: Assessment of safety,
diagnostic value and technical limitations
This is the first presentation of a CMR study in a patient
with the world’s first MR-conditional ICD. In this case, a
major problem related to the presence of the MR condi-
tional ICD was artifact caused by the device’s generator
which hampered the image quality in all sequences
performed. Considering previous studies, right chest
implantation of the ICD could probably have helped in
this setting and may be preferred in future ICD implan-
tations [199].
Clinical Implications of cardiac hyperpolarized magnetic
resonance imaging
This is a review of the novel CMR technique of 13C-hy-
perpolarization, which can augment the MR sensitivity
of the 13C nucleus by 4–5 orders of magnitude [200].
Metabolic tracers [1-13C] and [2-13C] pyruvate have
allowed significant advances in the understanding of
real-time myocardial metabolism in the normal and
diseased heart in vivo, in diabetes, ischaemic heart disease,
cardiac hypertrophy and heart failure. This review considers
results from animal models of disease and discusses how
these may translate into clinical practice.
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resonance spectroscopy
This is the first report of the 13C-hyperpolarisation
technique described above in the mouse heart, while
previous experimental studies have used larger animal
species [201]. This is important due to the ability to
manipulate specific genes in the mouse. The in vivo
metabolism of [1-13C]pyruvate was investigated; overnight
fasting and infusion of sodium dichloroacetate were used
to detect alterations in pyruvate dehydrogenase (PDH)
flux. A comparison of three commonly used control
mouse strains was performed revealing significant meta-
bolic differences between strains. Thus [1-13C]pyruvate
can be used to provide an in vivo cardiac metabolic profile
of transgenic mice.
Cardiovascular magnetic resonance of total and atrial
pericardial adipose tissue: a validation study and
development of a 3 dimensional pericardial adipose
tissue model
Pericardial adipose tissue (PAT) is an independent pre-
dictor of atrial fibrillation (AF), and atrial PAT may create
a substrate for AF. Using CMR, the authors developed
and validated a three-dimensional atrial PAT model in
sheep [202]. CMR-derived PAT estimates corresponded to
autopsy measurements, and reliability of CMR measures
was high. They conclude that the measurement of local
cardiac fat stores via this methodology could provide a
sensitive tool to examine the regional effect of fat depos-
ition on atrial substrate, which potentially may influence
AF ablation strategies in obese patients.
Assessment of the right ventricle with cardiovascular
magnetic resonance at 7T
It would be desirable given the increasing emphasis on
RV mass to predict outcomes to achieve higher spatial
resolution for better RV free wall depiction. In 9 healthy
volunteers CMR fast gradient echo cine (FGRE) imaging
at 7T was performed for functional and morphological
right ventricular assessment and compared with 1.5T
steady state free precession (SSFP) cine imaging [203].
There was good agreement with ventricular volumes
between 1.5T SSFP and 7T FGRE but FGRE at 7T
(1.3×1.3×4mm voxels) tended to overestimate RV volume
compared with SSFP at 1.5T (1.2×1.2×6mm voxels). FGRE
cine imaging at 7T resulted in lower image homogeneity
but received overall equal ratings for visually evaluated
image contrast and quality.
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